Skip to main content
Journal cover image

ITPA GENE POLYMORPHISMS SIGNIFICANTLY AFFECT HEMOGLOBIN DECLINE AND TREATMENT OUTCOMES IN HIV/HCV CO-INFECTED PATIENTS

Publication ,  Conference
Osinusi, A; Naggie, S; Poonia, S; Trippler, M; Hu, Z; Funk, E; Schlaak, JF; Fishbein, D; Masur, H; Polis, MA; Kottilil, S
Published in: HEPATOLOGY
October 1, 2011

Duke Scholars

Published In

HEPATOLOGY

ISSN

0270-9139

Publication Date

October 1, 2011

Volume

54

Start / End Page

854A / 854A

Location

San Francisco, CA

Publisher

WILEY-BLACKWELL

Conference Name

62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)

Related Subject Headings

  • Gastroenterology & Hepatology
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1107 Immunology
  • 1103 Clinical Sciences
  • 1101 Medical Biochemistry and Metabolomics
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Osinusi, A., Naggie, S., Poonia, S., Trippler, M., Hu, Z., Funk, E., … Kottilil, S. (2011). ITPA GENE POLYMORPHISMS SIGNIFICANTLY AFFECT HEMOGLOBIN DECLINE AND TREATMENT OUTCOMES IN HIV/HCV CO-INFECTED PATIENTS. In HEPATOLOGY (Vol. 54, pp. 854A-854A). San Francisco, CA: WILEY-BLACKWELL.
Osinusi, Anu, Susanna Naggie, Seerat Poonia, Martin Trippler, Zonghui Hu, Emily Funk, Joerg F. Schlaak, et al. “ITPA GENE POLYMORPHISMS SIGNIFICANTLY AFFECT HEMOGLOBIN DECLINE AND TREATMENT OUTCOMES IN HIV/HCV CO-INFECTED PATIENTS.” In HEPATOLOGY, 54:854A-854A. WILEY-BLACKWELL, 2011.
Osinusi A, Naggie S, Poonia S, Trippler M, Hu Z, Funk E, et al. ITPA GENE POLYMORPHISMS SIGNIFICANTLY AFFECT HEMOGLOBIN DECLINE AND TREATMENT OUTCOMES IN HIV/HCV CO-INFECTED PATIENTS. In: HEPATOLOGY. WILEY-BLACKWELL; 2011. p. 854A-854A.
Osinusi, Anu, et al. “ITPA GENE POLYMORPHISMS SIGNIFICANTLY AFFECT HEMOGLOBIN DECLINE AND TREATMENT OUTCOMES IN HIV/HCV CO-INFECTED PATIENTS.” HEPATOLOGY, vol. 54, WILEY-BLACKWELL, 2011, pp. 854A-854A.
Osinusi A, Naggie S, Poonia S, Trippler M, Hu Z, Funk E, Schlaak JF, Fishbein D, Masur H, Polis MA, Kottilil S. ITPA GENE POLYMORPHISMS SIGNIFICANTLY AFFECT HEMOGLOBIN DECLINE AND TREATMENT OUTCOMES IN HIV/HCV CO-INFECTED PATIENTS. HEPATOLOGY. WILEY-BLACKWELL; 2011. p. 854A-854A.
Journal cover image

Published In

HEPATOLOGY

ISSN

0270-9139

Publication Date

October 1, 2011

Volume

54

Start / End Page

854A / 854A

Location

San Francisco, CA

Publisher

WILEY-BLACKWELL

Conference Name

62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)

Related Subject Headings

  • Gastroenterology & Hepatology
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1107 Immunology
  • 1103 Clinical Sciences
  • 1101 Medical Biochemistry and Metabolomics